We studied the molecular mechanism of resistance in extended-spectrum b-lactamase (ESBL)producing Klebsiella pneumoniae isolated from a neonatal intensive care unit (NICU) of one of the hospitals in North India. A total of 3000 clinical samples were collected from a NICU (January 2009 to February 2011), of which 523 strains were K. pneumoniae positive and 262 of them were ESBL-producing K. pneumoniae strains. All of the ESBL-producing clinical isolates were susceptible to carbapenems. However, the majority of the clinical isolates (30-96 %) were resistant to a wide range of antibiotics including antibiotic/inhibitor combinations. The MIC values confirmed that these isolates were highly resistant to cephalosporins and aztreonam. In the 262 ESBL-producing K. pneumoniae isolates, 15 different enterobacterial repetitive intergenic consensus (ERIC)-PCR-typed phylogenetic groups were identified and reconfirmed by PFGE. Characterization of plasmids from each representative member of these phylogenetic groups revealed the presence of three plasmids of different sizes. Conjugation experiments confirmed the presence of different resistance markers only on the 154 kb plasmid. PCR amplification and sequence analysis revealed that bla CTX-M-3 , bla TEM-1 , bla SHV-1 , bla OXA-1 and armA were the predominant resistance markers. Plasmid-replicon typing showed that IncI1-Ic and IncFIA-FIB types are the most prevalent. This study shows the co-existence of multiple ESBL-encoding genes and their polyclonal dissemination among K. pneumoniae clinical isolates in the NICU of a North Indian hospital.
INTRODUCTION
Klebsiella pneumoniae is an opportunistic pathogen mainly responsible for nosocomial infection in the setting of neonatal intensive care units (NICUs) of hospitals (Bagattini et al., 2006) . It is a causative agent of pneumonia, urinary tract infection, intra-abdominal pathologies, conjunctivitis and central venous line-related infections (Parveen et al., 2011) . The infections caused by K. pneumoniae are hard to eradicate by using available antibiotics as an increasing number of cases of multidrug resistance have been reported from different parts of the world (Sikarwar & Batra, 2011) . A high frequency of nosocomial infections caused by K. pneumoniae have also been reported worldwide (Meatherall et al., 2009) . The strong selection pressure exerted by the indiscriminate use of b-lactam antibiotics has resulted in the emergence of new resistant strains of K. pneumoniae that carry multiple resistance gene markers (Sadeghifard et al., 2011) . Since 1983, nosocomial outbreaks of extendedspectrum b-lactamase (ESBL)-producing K. pneumoniae infections in Europe, the United States and South America have been reported (Lautenbach et al., 2001) . ESBLs are known as extended spectrum because they are able to hydrolyse a broader range of b-lactam antibiotics than the simple parent b-lactamases from which they are derived. Such ESBLs also have the ability to inactivate b-lactam antibiotics containing an oxyimino group, such as oxyiminocephalosporins (e.g. ceftazidime, ceftriaxone, cefotaxime), as well as oxyiminomonobactam. Furthermore, they are inhibited by b-lactamase inhibitors such as clavulanic acid and tazobactam. Bacteria having ESBLs marker on a plasmid are of serious concern because of cross-species dissemination of these markers (Haque et al., 2012; Xiong et al., 2004) . Clinical conditions and treatments predisposing to infection by such pathogens have been investigated mostly due to the prevalence of ESBL-producing K. pneumoniae in NICUs and there is a paucity of ESBL data on neonates, particularly in North India. In view of the present situation, we initiated our study to understand the mechanism of resistance among the K. pneumoniae isolates circulating in the NICU of a teaching hospital in North India.
METHODS
Study design and patient population. The study was conducted on the neonates admitted to the NICU (sick babies) of one of the hospitals in North India. It is a tertiary care unit of 1300 bed capacity, in which 90 beds were allotted for paediatric patients and 20 beds for the NICU. In our study period from January 2009 to February 2011, 3000 clinical samples were collected from NICU patients, and bacteria were detected in 785 (26.1 %) of cultured samples. Among these 785 bacterial samples, 523 strains were positive for K. pneumoniae as identified by using the Hi-Crome Kleb selective agar base identification kit (Himedia). Furthermore, in the 523 K. pneumoniae strains, 261 were found to be non-ESBL producing and 262 were ESBL producing. Our study was focused only on these 262 ESBL-producing K. pneumoniae strains; samples were collected from each patient, by sterile cotton swabs, from different body sites, such as the eyelid, nose, pharynx, body surface and rectum. Each neonate admitted to the ward was clinically examined on a daily basis. If any patient showed a deteriorated condition, the sampling was repeated. Information and history regarding the illness of the neonates were obtained from the parents and the consultant of the NICU. Clearance was obtained from the institute's ethical committee held on 6 July 2009. The criteria of sample collection were included or excluded on the basis of the state of sepsis. This was calculated by dividing the number of newborns with sepsis by the total number of newborns admitted to the NICU. This was a retrospective, hospital-based and single-centre study. Data collected from the medical records of each patient were recorded in standardized collection sheets, and included demographic information, birth weight, gestational age, gender, outcome and delivery data (type of delivery, maturity). Gestational age was classified into two distinct groups: 24-29 and ¢30 weeks. Birth weight categories were: 600-1499 and ¢1500 g. The definition of sepsis was based on a positive blood culture in the presence of clinical signs and symptoms of infection: tachypnea (respiratory rate .60 beats min 21 ) plus either grunting/ retraction or desaturation, temperature instability (,36 or .38 uC), heart rate .SD above normal for age (¢180 ¡100 beats min 21 ), lethargy/altered mental status, systolic pressure ,65 mmHg (infants ¡1 month), capillary refill time .3 s, white blood cell count (,4610 12 or .3.4610 13 cells l 21 , immature/total neutrophil ratio .0.2, Cardiopulmonary resuscitation .10 mg ml 21 , IL-6 or IL-8 .70 pg ml 21 ). Late-onset infection was defined when positive blood cultures were obtained after the first 72 h of life. Newborns that were younger than 3 days were excluded. When K. pneumoniae were isolated the definition of true infection was based on the presence of clinical symptoms strongly suggestive of infection, together with at least two blood cultures positive for K. pneumoniae strains, drawn on different occasions; otherwise, isolated K. pneumoniae was defined as a contamination. Cultures positive for organisms that were generally considered to be contaminants, including Gram-positive bacteria and fungi, were excluded from analysis. Copy isolates, defined as the same organism isolated from multiple blood cultures of the same patient within 48 h, and contaminant bacteria were excluded from this study.
Antibiotic-susceptibility profile of ESBL-producing K. pneumoniae isolates. The antimicrobial susceptibility of ESBL-producing K. pneumoniae isolates was determined by the standard disc diffusion method using Mueller-Hinton agar as per Clinical and Laboratory Standards Institute guidelines (CLSI, 2011) . The antibiotic discs used (Table 1) were obtained from Himedia.
ESBL and metallo-b-lactamase (MBL) detection. The ESBL phenotypic confirmatory test with discs with (30 mg each) ceftazidime, cefotaxime and ceftriaxone was performed for all the clinical isolates by the disc diffusion method on Mueller-Hinton agar plates with/without amoxyclav (20 mg amoxicillin+10 mg clavulanic acid). A ¢5 mm increase in the diameter of the inhibition zone with third generation cephalosporins indicated ESBL production (CLSI, 2011). MBL production was detected by a combined disc diffusion method employing two discs of imipenem, meropenem and ertapenem (10 mg in each disc), in which one of the discs contained 292 mg (10 ml of 0.1 M) anhydrous EDTA, placed 25 mm apart (centre to centre) on a Mueller-Hinton agar plate. An increase in the diameter of the inhibition zone by ¢4 mm around the imipenem+EDTA, meropenem+EDTA and ertapenem+EDTA as compared to that of the imipenem, meropenem and ertapenem alone indicated the presence of MBL (Franklin et al., 2006) .
MIC of ESBL-producing K. pneumoniae isolates. The MICs for all ESBL-producing K. pneumoniae isolates were determined by the CLSI micro-broth dilution method (CLSI, 2011) . Appropriate dilutions of b-lactam antibiotic solutions (Table 1) were prepared according to the report of an international collaborative study in which one part of the antimicrobial solution was added to nine parts of liquid Mueller-Hinton broth. The MIC values were compared with the breakpoints recommended by the CLSI (2011) guidelines. Escherichia coli ATCC 25922 strain was used as an ESBL-negative control and K. pneumoniae ATCC 700603 strain was used as an ESBL-positive control.
Molecular characterization by enterobacterial repetitive intergenic consensus (ERIC)-PCR. ERIC-PCR was carried out to analyse the genetic relatedness of the ESBL producers as described elsewhere (Aritua et al., 2007) .
Molecular characterization by PFGE. The genetic relatedness of the ESBL producers was determined by PFGE as described elsewhere with slight modification (Davis et al., 2003) .
Plasmid isolation and conjugation experiments. Plasmid DNA was extracted with a QIAprep spin miniprep kit as per the manufacturer's guidelines. The molecular size of multiple plasmids was identified by the Kieser method (Kieser, 1984) . Conjugal transfer of plasmid to sodium azide-resistant E. coli J53 recipient strain was performed by broth mating assay (Hussain et al., 2012) . Transconjugants were screened by double selection method on a Luria-Bertani agar plate containing sodium azide (100 mg l 21 ) and cefotaxime (4 mg l 21 ) or ceftazidime (4 mg l 21 ). Furthermore, aminoglycoside markers were also screened in the presence of sodium azide (100 mg l 21 ) and amikacin (30 mg l 21 ) (Wang et al., 2003) . Moreover, susceptibility testing of transconjugants was carried out by disc diffusion and micro-dilution methods. The conjugation experiment was further confirmed by filter method (Courvalin et al., 1985) . Furthermore, plasmids of 16S rRNA methylase genes were transferred into the recipient, E. coli DH5a, by transformation method.
PCR amplification and sequence analysis of bla genes.
Plasmids from ESBL-producing K. pneumoniae isolates were screened by PCR for the following b-lactamase genes -bla CTX-M , bla TEM , bla SHV , bla OXA-1 , bla KPC , bla NDM-1 , ampC and armA -using oligonucleotide specific primers as given in Table 2 (Pagani et al., 2003; Galimand et al., 2003; Versalovic et al., 1991; Guessennd et al., 2008 presence of integron was screened as described elsewhere (Guerra et al., 2000; Galimand et al., 2003) . The amplified products were sequenced using an ABI 3130 genetic analyser (Applied Biosystems). The obtained nucleotide sequences were searched for similar sequences in the National Centre for Biotechnology Information (NCBI) database by using its BLAST program (http//www.ncbi.nlm.nih.gov).
Plasmid-replicon typing. Plasmid-replicon typing among Enterobacteriaceae was carried out by using a method described elsewhere (Carattoli et al., 2005) . Plasmid DNA was amplified by five multiplex and three simplex PCRs using 18 pair of primers (Table 2) 
RESULTS
The present study was carried out on samples isolated from the NICU of one of the hospitals in North India over a period of more than 2 years. From a total of 3000 neonates who were screened for the nosocomial infection in the NICU, 523 (17.4 %) were found to have K. pneumoniae strains. The antibiotic-susceptibility tests confirmed the detection of 262 (50.0 %) ESBL-producing K. pneumoniae strains.
Antibiotic-susceptibility profile of ESBLproducing K. pneumoniae isolates Antibiotic-susceptibility testing was performed for all 262 ESBL-producing K. pneumoniae isolates and the results are presented in Table 1 . Our study clearly indicates that ESBL-producing K. pneumoniae isolates were 100 % resistant against antibiotics of the b-lactam group (ampicillin, penicillin and piperacillin were used as a control to check TGCCGTTTCACCTCGTGAGTA  471  AF250878  HI2  TTTCTCCTGAGTCACCTGTTAACAC  GGCTCACTACCGTTGTCATCCT  644  BX664015  I1  CGAAAGCCGGACGGCAGAA  TCGTCGTTCCGCCAAGTTCGT  139  M20413  X  AACCTTAGAGGCTATTTAAGTTGCTGAT  TGAGAGTCAATTTTTATCTCATGTTTTAGC  376  Y00768  L/M  GGATGAAAACTATCAGCATCTGAAG  CTGCAGGGGCGATTCTTTAGG  785  U27345  N  GTCTAACGAGCTTACCGAAG  GTTTCAACTCTGCCAAGTTC  559  NC-003292  FIA  CCATGCTGGTTCTAGAGAAGGTG  GTATATCCTTACTGGCTTCCGCAG  462  J01724  FIB  GGAGTTCTGACACACGATTTTCTG  CTCCCGTCGCTTCAGGGCATT  702  M26308  W  CCTAAGAACAACAAAGCCCCCG  GGTGCGCGGCATAGAACCGT  242  U12441  Y  AATTCAAACAACACTGTGCAGCCTG  GCGAGAATGGACGATTACAAAACTTT  765  KO2389  P  CTATGGCCCTGCAAACGCGCCAGAAA  TCACGCGCCAGGGCGCAGCC  534  M20134  FIC  GTGAACTGGCAGATGAGGAAGG  TTCTCCTCGTCGCCAAACTAGAT  262  AH003523  A/C  GAGAACCAAAGACAAAGACCTGGA  ACGACAAACCTGAATTGCCTCCTT  465  X73674  T  TTGGCCTGTTTGTGCCTAAACCAT  CGTTGATTACACTTAGCTTTGGAC  750  K00053  FII  CTGTCGTAAGCTGATGGC  CTCTGCCACAAACTTCAGC  270  AE006471  F  TGATCGTTTAAGGAATTTTG  GAAGATCAGTCACACCATCC  270  AY234375  K  GCGGTCCGGAAAGCCAGAAAAC  TCTTTCACGAGCCCGCCAAA  160  M93063  B/O  GCGGTCCGGAAAGCCAGAAAAC  TCTGCGTTCCGCCAAGTTCGA  159  M28718 S. Z. Ali, S. M. Ali and A. U. Khan 1156
Microbiology 160 the susceptibility/resistance pattern), whereas 45-88 % resistance was observed against first, second and third generation cephalosporins (cefalotin, cefazolin, cefuroxime, cefoxitin, ceftazidime and cefotaxime). Furthermore, the resistance against aminoglycosides (tobramycin and gentamicin), and fluoroquinolones and quinolone (ciprofloxacin and nalidixic acid), was found to be 43-75 and 38-80 %, respectively. The total antibiogram can be seen in Table 1 . However, we did not find MBL-producing strains in the NICU during the study period. Moreover, only 15, 18, 30, 30, 37, 38 and 43 % of ESBL-producing K. pneumoniae isolates were resistant against cefepime/tazobactam, ceftriaxone/tazobactam, ceftriaxone/clavulanic acid, fourth generation cephalosporin (cefepime), ceftriaxone/sulbactam, gatifloxacin and amikacin, respectively. It is clear that ESBL-producing K. pneumoniae isolates showed significant resistance against a broad spectrum of antibiotics.
Molecular typing by ERIC-PCR and PFGE
ERIC-PCR was performed for type 262 strains of ESBLproducing K. pneumoniae (data not shown) in different phylogenetic groups. On the basis of the ERIC-PCR profile, the different strains under study were categorized in 15 different phylogenetic groups (Aa-Ao) on the basis of the number of bands (3-5 bands of 500-1000 bp) and their relative mobility (Table S1 , available in the online Supplementary Material). It was found that the Ad group was the most frequently observed group in the studied isolates as it comprises 78 of 262 strains (29.77 %). For PFGE, one isolate from each phylogenetic group was randomly selected to further confirm that these isolates belonged to different groups (data not shown).
Antibiotic MICs for ESBL-producing K. pneumoniae isolates One member of each phylogenetic group was used to determine the MICs of cephalosporins and a monobactam, and the results are presented in Table 3 . All the isolates showed a high level of antibiotic resistance for the different generations of cephalosporins, including ceftazidime and the monobactam (aztreonam). The individual activity by the antibiotic showed a resistant pattern against all the tested strains, whereas in combination with inhibitors the MICs dramatically decreased by 4-16-fold. Furthermore, out of all inhibitors that were used in combination, tazobactam showed the best activity by reducing the MIC value up to 1 mg l 21 , except with ceftriaxone (no remarkable reduction of MIC when in combination with different inhibitors was observed).
Plasmid-mediated marker transfer
Plasmid isolation and characterization revealed that the ESBL-producing K. pneumoniae strains harbour three plasmids of different molecular sizes (28, 64 and 154 kb) (data not shown), in a randomly selected member of each phylogenetic group (Table 4) . These plasmids carried different genes that were responsible for imparting resistance against extended-spectrum cephalosporins. Susceptibility testing of transconjugants showed simultaneous resistance to more than one group of antibiotics (multidrug-resistance phenotype), including resistance to all generations of cephalosporins (Table 1) . Conjugation and filter methods showed transfer of a high-level aminoglycoside-resistance marker (armA). The transconjugants and transformants were highly resistant to amikacin, gentamicin and tobramycin (MICs ¢256 mg ml 21 ) (data not shown). The results of PCR and sequence analyses revealed that bla CTX-M-3 , bla TEM-1 and bla SHV-1 were co-transferred with armA on plasmids to the recipients (Table 4 ). Out of the three plasmids, one that was consistently transferred after transconjugation was the 154 kb plasmid (data not shown).
PCR amplification and sequence analysis of bla genes
The 262 ESBL-producing K. pneumoniae isolates were grouped into 15 different phylogenetic groups. The presence of bla genes, armA and integron was detected by PCR, using one representative isolate from each phylogenetic group. The PCR products were further sequenced to show the resistance marker of bla genes, armA and integron (Table 4 ). Of 15 selected K. pneumoniae isolates, all 15 (100 %) had bla CTX-M-3 and bla OXA-1 , 13 (87 %) were carrying bla TEM-1 , 10 (67 %) were found to be positive for bla SHV-1 and 9 (60 %) were found to have armA. Class 1 integron was also detected in all 15 (100 %) isolates, carrying sul1 and int1 genes, flanked by 39 and 59 conserved segments (Table 3) . Moreover, none of the isolates were found to be positive for bla KPC , bla VIM , bla OXA-48 , bla OXA-10 , bla OXA-9 and bla NDM-1 .
Plasmid-replicon typing
The plasmid-replicon typing revealed that bla CTX-M bla TEM , bla SHV and armA genes were present on plasmids of IncHI2, IncI1-Ic, IncFIB and IncFIA-FIB replicon types, present in the 15 representative K. pneumoniae strains ( Table 4 ). The replicon types IncI1-Ic and IncFIA-FIB were most prevalent in ESBL-producing K. pneumoniae isolates.
DISCUSSION
K. pneumoniae has been associated with different types of infections and one of the most important aspects of K. pneumoniae-associated infection is the emergence of multidrug-resistant strains, particularly those involved in nosocomial diseases (Sikarwar & Batra, 2011) . Epidemic and endemic nosocomial infections caused by ESBL-producing K. pneumoniae represent a persistent problem in many parts of the world, especially in intensive care units (Kristo et al., 2013) , while TEM and SHV type ESBL-producing K. pneumoniae are most commonly reported . The high prevalence of these drug-resistant strains has necessitated the requirement of a rapid and accurate identification of resistance markers in K. pneumoniae. However, spread of resistance markers by horizontal gene transfer is not the only mechanism for the spread of resistance genes in the environment. The presence of genetic elements (integrons and insertion sequences) has also been reported as a key player in the emergence of multidrugresistant bacteria. ESBL-producing K. pneumoniae strains showed resistance to a broad range of antibiotics of different groups, like b-lactams, extended-spectrum cephalosporins, aminoglycosides, monobactams, amoxicillin/clavulanic acid, tetracycline, oxacillin, co-trimoxazole and various antibiotic/inhibitor combinations. Cephalosporins have been widely used as monotherapy and in combination with aminoglycosides for the treatment of Klebsiella infection. These antibiotics are inactivated by an array of different ESBLs that have evolved by stepwise mutation of TEM/SHV type b-lactamases (Hawkey & Jones, 2009 ).
Moreover, among our 262 K. pneumoniae strains, each representative isolate of the different phylogenetic groups showed the multidrug-resistance phenotype (i.e. resistant to three or more different classes of antimicrobial agents). It may be due to decreased permeability of porins or AmpC b-lactamase production (Mohamudha Parveen et al., 2010) . The higher proportion of resistance to tetracycline (73 %) and co-trimoxazole (85 %) is mainly due to the wide use of these antibiotics over the past decade in our region (Shakil et al., 2010) . However, 95-100 % K. pneumoniae isolates were sensitive to carbapenems. Thus, this group of drugs can be used as the drugs of choice to check the spread of K. pneumoniae.
Our work revealed a high prevalence of K. pneumoniae strains that are resistant to inhibitors and antibiotic/ inhibitor combinations. We found that 93 % isolates of K. pneumoniae were resistant to amoxyclav. The antibiotic/ inhibitor combinations showed the following resistance order: ceftazidime/sulbactam . cefotaxime/sulbactam . ceftazidime/tazobactam . cefotaxime/clavulanic acid . cefotaxime/tazobactam . ceftriaxone/sulbactam . ceftriaxone/clavulanic acid . ceftriaxone/tazobactam . cefepime/ tazobactam (Table 1 ). The resistance of K. pneumoniae to blactamase inhibitors and antibiotic/inhibitor combinations has been attributed to the simultaneous production of CTX-M-3 and SHV-12 enzymes (Liu et al., 2009 ).
The presence of resistance genes on large plasmids of varying sizes (7 to 200 kb) has been confirmed by earlier reports (Mshana et al., 2009) . And each representative member of all 15 phylogenetic groups in our study was carrying a mega plasmid. Conjugation experiments showed that the resistance marker genes were present on the plasmid, and thus can be transferred horizontally. The sequence analysis using the NCBI BLAST program confirmed the presence of bla CTX-M-3 , bla OXA-1 , bla TEM-1 and bla SHV-1 genes along with armA. This study revealed an important finding that bla CTX-M-3 and bla OXA-1 is prevalent in 100 % of the K. pneumoniae isolates, whereas 87%, 67 and 9 % of the isolates harboured bla TEM-1 , bla SHV-1 and armA, respectively. Furthermore, these plasmids had class I integrons carrying sul1 and int1 genes, flanked by 39 and 59 conserved sequences.
The replicon typing showed that plasmids carrying the resistance marker genes belong to IncHI2, IncI1c, IncFIB and IncFIA-FIB. This is, to the best of our knowledge, the first study to report the prevalence of plasmid types IncI1-Ic and IncFIA-FIB in ESBL-producing K. pneumoniae isolates in North India. Our study also demonstrated that ESBL-producing K. pneumoniae isolates from the NICU of one of the hospitals in North India harboured bla CTX-M-3 , bla TEM-1 , bla SHV-1 and bla OXA-1 resistance marker genes. The co-existence of multiple ESBL-encoding genes (bla CTX-M-3 , bla TEM-1 and bla SHV-12 ) in K. pneumoniae has also been reported earlier (Romero et al., 2007) .
Conclusion and future perspective
In conclusion, this study shows the polyclonal dissemination of ESBL-producing strains and the co-existence of multiple ESBL-encoding genes (bla CTX-M-3 bla TEM-1 , bla SHV-1 and bla OXA-1 ) in clinical isolates. Furthermore, plasmid types IncI1-Ic and IncFIA-FIB were the most prevalent in ESBLproducing K. pneumoniae isolates in the NICU of the North Indian tertiary care hospital. This study has given an insight into the mechanism of antibiotic resistance in K. pneumoniae, which is associated with nosocomial infections.
